Prevention of the surface resorption of bone grafts by topical application of bisphosphonate on different carrier materials

Clinical Oral Investigations

Volumn 18, Issue 9, 2014, Pages 2203-2211

  Möller, Björn ^a   Wiltfang, Jörg ^a   Acil, Yahya ^a   Gierloff, Matthias ^a   Lippross, Sebastian ^a   Terheyden, Hendrik ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Red Cross Hospital   (Germany)

Author keywords

Bisphosphonate; Bone graft; Guided tissue regeneration; Membrane; Surface resorption

Indexed keywords

ALENDRONIC ACID; BIO-GIDE; BIO-OSS; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN; MINERAL;

ALVEOLAR RIDGE AUGMENTATION; ANIMAL; BOVINE; MANDIBLE; MICRORADIOGRAPHY; NECROSIS; OSTEOLYSIS; PIG; PREVENTION AND CONTROL; PROCEDURES; STAINING; SURGERY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ALENDRONATE; ALVEOLAR RIDGE AUGMENTATION; ANIMALS; BONE RESORPTION; CATTLE; COLLAGEN; DIPHOSPHONATES; MANDIBLE; MICRORADIOGRAPHY; MINERALS; NECROSIS; STAINING AND LABELING; SWINE;

EID: 84912001046     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-014-1202-9     Document Type: Article

References (36)

1. Davies JE (2003) Understanding peri-implant endosseous healing. J Dent Educ 67(8):932–949
2. Johansson B, Grepe A, Wannfors K, Hirsch JM (2001) A clinical study of changes in the volume of bone grafts in the atrophic maxilla. Dentomaxillofac Radiol 30(3):157–161. doi:10.1038/sj/dmfr/4600601
3. Maiorana C, Beretta M, Salina S, Santoro F (2005) Reduction of autogenous bone graft resorption by means of bio-oss coverage: a prospective study. Int J Periodontics Restorative Dent 25(1):19–25
4. Schlegel A (2007) Regenerative Techniken. Thieme Verlag, Stuttgart
5. von Arx T, Buser D (2006) Horizontal ridge augmentation using autogenous block grafts and the guided bone regeneration technique with collagen membranes: a clinical study with 42 patients. Clin Oral Implants Res 17(4):359–366. doi:10.1111/j.1600-0501.2005.01234.x
6. Tawil G, El-Ghoule G, Mawla M (2001) Clinical evaluation of a bilayered collagen membrane (Bio-Gide) supported by autografts in the treatment of bone defects around implants. Int J Oral Maxillofac Implants 16(6):857–863
7. Hammerle CH, Jung RE, Yaman D, Lang NP (2008) Ridge augmentation by applying bioresorbable membranes and deproteinized bovine bone mineral: a report of twelve consecutive cases. Clin Oral Implants Res 19(1):19–25. doi:10.1111/j.1600-0501.2007.01407.x
8. Aspenberg P, Astrand J (2002) Bone allografts pretreated with a bisphosphonate are not resorbed. Acta Orthop Scand 73(1):20–23. doi:10.1080/000164702317281350
9. Tengvall P, Skoglund B, Askendal A, Aspenberg P (2004) Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 25(11):2133–2138
10. Skoglund B, Holmertz J, Aspenberg P (2004) Systemic and local ibandronate enhance screw fixation. J Orthop Res 22(5):1108–1113. doi:10.1016/j.orthres.2003.12.015
11. Reginster JY, Malaise O, Neuprez A, Jouret VE, Close P (2007) Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date. Drugs Aging 24(5):351–359
12. Kohno N (2008) Treatment of breast cancer with bone metastasis: bisphosphonate treatment—current and future. Int J Clin Oncol 13(1):18–23. doi:10.1007/s10147-007-0726-2
13. Berenson JR (2002) Treatment of hypercalcemia of malignancy with bisphosphonates. Semin Oncol 29(6 Suppl 21):12–18. doi:10.1053/sonc.2002.37417
14. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88(12 Suppl):2961–2978. doi:10.1002/1097-0142(20000615)88:12+<2961
15. Hosfield DJ, Zhang Y, Dougan DR, Broun A, Tari LW, Swanson RV, Finn J (2004) Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis. J Biol Chem 279(10):8526–8529. doi:10.1074/jbc.C300511200
16. Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, Shin YI, Lee MS, Kim HS, Kim JW, Chun CH, Cho HJ, Hong GY, Juhng SK, Yoon KH, Park BH, Bae JM, Han JK, Oh J (2009) Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull 32(7):1193–1198
17. Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567–1575. doi:10.1016/j.joms.2005.07.010
18. Stadelmann VA, Terrier A, Gauthier O, Bouler JM, Pioletti DP (2009) Prediction of bone density around orthopedic implants delivering bisphosphonate. J Biomech 42(9):1206–1211. doi:10.1016/j.jbiomech.2009.03.024
19. Mitsuta T, Horiuchi H, Shinoda H (2002) Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis. J Periodontol 73(5):479–486. doi:10.1902/jop.2002.73.5.479
20. Komatsu K, Shimada A, Shibata T, Shimoda S, Oida S, Kawasaki K, Nifuji A (2008) Long-term effects of local pretreatment with alendronate on healing of replanted rat teeth. J Periodontal Res 43(2):194–200. doi:10.1111/j.1600-0765.2007.01012.x
21. Bosemark P, Isaksson H, McDonald MM, Little DG (2013) Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength. Acta Orthop 84(1):106–111. doi:10.3109/17453674.2013.773123
22. Hönig JF, Merten HA (1993) Das Göttinger Miniaturschwein (GMS) als Versuchstier in der human-medizinischen osteologischen Grundlagenforschung. Zeitschrift für Zahnärztliche Implantologie 9:244–245
23. Donath K, Breuner G (1982) A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 11(4):318–326
24. Tagil M, Astrand J, Westman L, Aspenberg P (2004) Alendronate prevents collapse in mechanically loaded osteochondral grafts: a bone chamber study in rats. Acta Orthop Scand 75(6):756–761
25. Yaffe A, Iztkovich M, Earon Y, Alt I, Lilov R, Binderman I (1997) Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 68(9):884–889
26. Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF (1996) A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res 11(2):150–159. doi:10.1002/jbmr.5650110203
27. Nishida S, Tsubaki M, Hoshino M, Namimatsu A, Uji H, Yoshioka S, Tanimori Y, Yanae M, Iwaki M, Irimajiri K (2005) Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2. Biochem Biophys Res Commun 328(1):91–97. doi:10.1016/j.bbrc.2004.12.145
28. Acil Y, Moller B, Niehoff P, Rachko K, Gassling V, Wiltfang J, Simon MJ (2011) The cytotoxic effects of three different bisphosphonates in vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. J Craniomaxillofac Surg. doi:10.1016/j.jcms.2011.10.024
29. Houshmand B, Rahimi H, Ghanavati F, Alisadr A, Eslami B (2007) Boosting effect of bisphosphonates on osteoconductive materials: a histologic in vivo evaluation. J Periodontal Res 42(2):119–123. doi:10.1111/j.1600-0765.2006.00923.x
30. Ruggiero SL (2008) Bisphosphonate-related osteonecrosis of the jaws. Compend Contin Educ Dent 29(2):96–98, 100–102, 104–105
31. Kawata T, Tenjou K, Tokimasa C, Fujita T, Kaku M, Matsuki A, Kohno S, Tsutsui K, Ohtani J, Motokawa M, Shigekawa M, Tohma Y, Tanne K (2004) Effect of alendronate on osteoclast differentiation and bone volume in transplanted bone. Exp Anim 53(1):47–51
32. Mozzati M, Martinasso G, Maggiora M, Scoletta M, Zambelli M, Carossa S, Oraldi M, Muzio G, Canuto RA (2012) Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. Clin Oral Investig 48:817–21. doi:10.1007/s00784-012-0800-7
33. Acil Y, Moller B, Niehoff P, Rachko K, Gassling V, Wiltfang J, Simon MJ (2012) The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. J Craniomaxillofac Surg 40(8):e229–235. doi:10.1016/j.jcms.2011.10.024
34. Diel IJ, Bergner R, Grotz KA (2007) Adverse effects of bisphosphonates: current issues. J Support Oncol 5(10):475–482
35. Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104(1):83–93. doi:10.1002/cncr.21130
36. Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA (2008) Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139(12):1674–1677